Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
iCAD presents new data for Xoft Brain IORT at ASCO » 17:05
05/13/20
05/13
17:05
05/13/20
17:05
ICAD

iCAD

$11.99 /

-0.1 (-0.83%)

iCAD announced positive…

iCAD announced positive new clinical data supporting the Xoft Axxent Electronic Brachytherapy, eBx, System for the treatment of glioblastoma multiforme,GBM, will be presented at the American Society of Clinical Oncology, ASCO Virtual Scientific Program, which will take place May 29-31. "This represents a significant milestone for the company, as it further validates Xoft intraoperative radiation therapy in certain types of brain tumors and demonstrates the impact that this unique technology offers," according to Michael Klein, Chairman and CEO of iCAD. "GBM is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months.1,2 With almost 297,000 cases of brain and nervous system tumors diagnosed worldwide per year,3 this exciting new application for the Xoft System could substantially expand our addressable market, but more importantly, it has the potential to extend patients' lives."

ShowHide Related Items >><<
ICAD iCAD
$11.99 /

-0.1 (-0.83%)

ICAD iCAD
$11.99 /

-0.1 (-0.83%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
ICAD iCAD
$11.99 /

-0.1 (-0.83%)

ICAD iCAD
$11.99 /

-0.1 (-0.83%)

On The Fly
Fly Intel: After-Hours Movers » 19:08
05/11/20
05/11
19:08
05/11/20
19:08
CBAY

CymaBay

$1.84 /

+0.045 (+2.51%)

, IIVI

II-VI

$36.29 /

+0.45 (+1.26%)

, VRRM

Verra Mobility

$9.12 /

+0.08 (+0.88%)

, SGRY

Surgery Partners

$10.82 /

-0.12 (-1.10%)

, GDOT

Green Dot

$30.78 /

-0.73 (-2.32%)

, GO

Grocery Outlet

$36.71 /

+0.01 (+0.03%)

, CZR

Caesars

$9.65 /

-0.06 (-0.62%)

, NVAX

Novavax

$24.59 /

+5.86 (+31.29%)

, AMC

AMC Entertainment

$5.32 /

+1.225 (+29.91%)

, EB

Eventbrite

$10.51 /

+0.26 (+2.54%)

, DIOD

Diodes

$50.09 /

-0.31 (-0.62%)

, ICAD

iCAD

$12.31 /

-0.55 (-4.28%)

, TLRY

Tilray

$8.09 /

+0.305 (+3.92%)

, TME

Tencent Music

$11.43 /

+0.39 (+3.53%)

, AIMT

Aimmune

$17.89 /

+0.28 (+1.59%)

, SGMO

Sangamo

$9.08 /

+0.4 (+4.61%)

, HALO

Halozyme

$24.82 /

+1.24 (+5.26%)

, FATE

Fate Therapeutics

$30.30 /

+1.45 (+5.03%)

, PLYA

Playa Hotels & Resorts

$2.11 /

+0.06 (+2.93%)

, JCOM

j2 Global

$81.40 /

+0.03 (+0.04%)

, SGMS

Scientific Games

$12.97 /

-0.18 (-1.37%)

, MAXR

Maxar Technologies

$11.61 /

+0.37 (+3.29%)

, FSCT

ForeScout

$32.12 /

-0.08 (-0.25%)

, OMER

Omeros

$17.01 /

+0.99 (+6.18%)

, SCPL

SciPlay

$12.22 /

+0.33 (+2.78%)

, HTZ

Hertz

$3.18 /

-0.07 (-2.15%)

, AKBA

Akebia

$12.85 /

+0.86 (+7.17%)

, QTWO

Q2 Holdings

$81.58 /

-1.04 (-1.26%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
CBAY CymaBay
$1.84 /

+0.045 (+2.51%)

03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
03/13/20 Oppenheimer
CymaBay upgraded to Outperform from Perform at Oppenheimer
03/13/20 Cantor Fitzgerald
CymaBay upgraded to Overweight from Neutral at Cantor Fitzgerald
02/26/20 Citi
Citi upgrades Intercept to Buy on peak sales potential of Ocaliva
IIVI II-VI
$36.29 /

+0.45 (+1.26%)

03/23/20
Fly Intel: Top analyst initiations
03/23/20 Barclays
Barclays starts II-VI with Overweight rating, $31 price target
03/23/20 Barclays
II-VI initiated with an Overweight at Barclays
03/20/20 Craig-Hallum
II-VI price target lowered to $35 from $45 at Craig-Hallum
VRRM Verra Mobility
$9.12 /

+0.08 (+0.88%)

04/29/20 Credit Suisse
Verra Mobility price target lowered to $10.50 from $17 at Credit Suisse
03/18/20 Deutsche Bank
Verra Mobility price target lowered to $12 from $18 at Deutsche Bank
01/24/20 Credit Suisse
Credit Suisse sees more M&A in 2020 for FinTechs, processors and payments
01/23/20 Credit Suisse
Verra Mobility initiated with an Outperform at Credit Suisse
SGRY Surgery Partners
$10.82 /

-0.12 (-1.10%)

04/27/20 Benchmark
Surgery Partners upgraded to Buy on faster recovery timeline at Benchmark
04/27/20 Benchmark
Surgery Partners upgraded to Buy from Hold at Benchmark
04/21/20
Envision bankruptcy report has limited read-throughs, says Benchmark
03/24/20 RBC Capital
Surgery Partners price target lowered to $14 from $19 at RBC Capital
GDOT Green Dot
$30.78 /

-0.73 (-2.32%)

04/07/20 Craig-Hallum
Green Dot assumed with a Buy at Craig-Hallum
03/26/20 SunTrust
Green Dot price target lowered to $40 from $48 at SunTrust
03/26/20 BTIG
BTIG upgrades Green Dot to Buy on 'game-changer' CEO hire
03/25/20 BTIG
Green Dot upgraded to Buy from Neutral at BTIG
GO Grocery Outlet
$36.71 /

+0.01 (+0.03%)

01/29/20
Fly Intel: Top five analyst initiations
01/29/20 Craig-Hallum
Grocery Outlet initiated with a Buy at Craig-Hallum
11/12/19 Jefferies
Grocery Outlet comps remain well above industry trend, says Jefferies
08/14/19 Jefferies
Grocery Outlet price target raised to $50 from $41 at Jefferies
CZR Caesars
$9.65 /

-0.06 (-0.62%)

04/17/20 SunTrust
Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust
04/17/20 SunTrust
Caesars upgraded to Buy from Hold at SunTrust
04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
04/03/20 Stifel
Eldorado Resorts shares offer 250% upside from current levels, says Stifel
NVAX Novavax
$24.59 /

+5.86 (+31.29%)

04/30/20 H.C. Wainwright
Novavax price target raised to $33 from $24 at H.C. Wainwright
04/24/20 B. Riley FBR
Novavax price target raised to $29 from $20 at B. Riley FBR
04/09/20 Ladenburg
Ladenburg ups Novavax target to $28 on 'potent' COVID vaccine candidate
03/27/20 B. Riley FBR
Novavax price target raised to $20 from $15 at B. Riley FBR
AMC AMC Entertainment
$5.32 /

+1.225 (+29.91%)

05/11/20 B. Riley FBR
Amazon buyout may not appeal to AMC shareholders, says B. Riley FBR
04/30/20 Imperial Capital
AMC Entertainment price target raised to $3 from $2 at Imperial Capital
04/23/20 Macquarie
AMC Entertainment downgraded to Neutral from Outperform at Macquarie
04/22/20 JPMorgan
JPMorgan downgrades EPR after only15% of April rents get collected
EB Eventbrite
$10.51 /

+0.26 (+2.54%)

04/03/20 SunTrust
Eventbrite price target lowered to $8 from $19 at SunTrust
02/28/20 SunTrust
Eventbrite price target lowered to $19 from $22 at SunTrust
02/28/20 RBC Capital
Eventbrite downgraded to Sector Perform from Outperform at RBC Capital
01/24/20 William Blair
Data shows Eventbrite fan engagement is growing, says William Blair
DIOD Diodes
$50.09 /

-0.31 (-0.62%)

04/17/20 Baird
Diodes upgraded to Outperform at Baird
04/17/20 Baird
Diodes upgraded to Outperform from Neutral at Baird
03/19/20 Wells Fargo
Diodes price target lowered to $55 from $64 at Wells Fargo
02/10/20 Baird
Baird removes 'Fresh Pick Designation' on Diodes for China disruptions
ICAD iCAD
$12.31 /

-0.55 (-4.28%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
TLRY Tilray
$8.09 /

+0.305 (+3.92%)

04/16/20 Jefferies
Tilray downgraded to Underperform following 'short squeeze' at Jefferies
04/16/20 Jefferies
Tilray downgraded to Underperform from Hold at Jefferies
04/09/20 Consumer Edge
Tilray downgraded to Equal Weight from Overweight at Consumer Edge
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
TME Tencent Music
$11.43 /

+0.39 (+3.53%)

03/18/20 BOCOM
Tencent Music upgraded to Neutral from Sell at BOCOM
03/12/20 Morgan Stanley
Tencent Music upgraded to Overweight from Equal Weight at Morgan Stanley
02/25/20 Goldman Sachs
Huya downgraded to Neutral on cost inflation at Goldman Sachs
02/19/20
Fly Intel: Top five analyst downgrades
AIMT Aimmune
$17.89 /

+0.28 (+1.59%)

04/06/20 Citi
DBV's Viaskin Peanut more likely than not to be approved, says Citi
04/06/20 Piper Sandler
Aimmune launch 'thrown a wrench' amid COVID-19, says Piper Sandler
03/23/20 Cantor Fitzgerald
Aimmune price target lowered to $32 from $64 at Cantor Fitzgerald
03/18/20 JMP Securities
Aimmune downgraded to Market Perform from Outperform at JMP Securities
SGMO Sangamo
$9.08 /

+0.4 (+4.61%)

02/28/20 William Blair
Biogen deal with Sangamo unlikely to have near-term impact, says William Blair
02/03/20 Evercore ISI
Evercore ISI downgrades Crispr Therapeutics, questions relative valuation
08/26/19
Fly Intel: Top five analyst initiations
08/26/19 H.C. Wainwright
Sangamo initiated with a Buy at H.C. Wainwright
HALO Halozyme
$24.82 /

+1.24 (+5.26%)

05/04/20 Cantor Fitzgerald
Halozyme price target raised to $39 from $35 at Cantor Fitzgerald
02/05/20
Fly Intel: Top five analyst upgrades
02/05/20 Piper Sandler
Halozyme upgraded to Overweight from Neutral at Piper Sandler
FATE Fate Therapeutics
$30.30 /

+1.45 (+5.03%)

04/02/20 Piper Sandler
Fate Therapeutics price target raised to $63 from $57 at Piper Sandler
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Citi
Fate Therapeutics price target raised to $41 from $26 at Citi
03/04/20 Barclays
Fate Therapeutics initiated with an Overweight at Barclays
PLYA Playa Hotels & Resorts
$2.11 /

+0.06 (+2.93%)

04/29/20 SunTrust
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
04/29/20 SunTrust
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
04/07/20 Citi
Playa Hotels & Resorts downgraded to Sell from Neutral at Citi
04/03/20 Deutsche Bank
Playa Hotels & Resorts price target lowered to $7 from $11 at Deutsche Bank
JCOM j2 Global
$81.40 /

+0.03 (+0.04%)

04/29/20
Fly Intel: Top five analyst initiations
04/29/20 JPMorgan
j2 Global initiated with an Overweight, $105 target at JPMorgan
04/29/20 JPMorgan
j2 Global initiated with an Overweight at JPMorgan
04/02/20
Fly Intel: Top five analyst initiations
SGMS Scientific Games
$12.97 /

-0.18 (-1.37%)

04/16/20 Jefferies
Gaming equipment suppliers 'managing around' fortunes of casinos, says Jefferies
04/15/20 Craig-Hallum
Scientific Games price target lowered to $20 from $55 at Craig-Hallum
02/20/20 Deutsche Bank
Scientific Games price target lowered to $23 from $29 at Deutsche Bank
02/19/20 Craig-Hallum
Scientific Games price target lowered to $55 from $60 at Craig-Hallum
MAXR Maxar Technologies
$11.61 /

+0.37 (+3.29%)

01/15/20 Credit Suisse
Maxar Technologies upgraded to Neutral from Underperform at Credit Suisse
01/08/20 JPMorgan
Maxar Technologies price target raised to $25 from $15 at JPMorgan
12/30/19 Raymond James
Maxar Technologies downgraded to Market Perform from Outperform at Raymond James
12/19/19 CIBC
Maxar Technologies upgraded to Neutral from Underperformer at CIBC
FSCT ForeScout
$32.12 /

-0.08 (-0.25%)

02/18/20 Baird
ForeScout acquired, Baird downgrades to Neutral
02/18/20 Baird
ForeScout downgraded to Neutral from Outperform at Baird
02/07/20 Berenberg
ForeScout downgraded to Hold from Buy at Berenberg
02/07/20 Monness Crespi
ForeScout downgraded to Neutral from Buy at Monness Crespi
OMER Omeros
$17.01 /

+0.99 (+6.18%)

03/04/20 Wedbush
Omeros price target raised to $22 from $18 at Wedbush
03/03/20 Cantor Fitzgerald
Omeros shares can 'significantly rerate' from here, says Cantor Fitzgerald
11/05/19 H.C. Wainwright
Omeros recent selloff appears unwarranted, says H.C. Wainwright
SCPL SciPlay
$12.22 /

+0.33 (+2.78%)

04/22/20 BofA
SciPlay upgraded to Neutral from Underperform at BofA
04/22/20 BofA
SciPlay upgraded to Neutral from Underperform at BofA
04/17/20 SunTrust
SciPlay upgraded to Buy at SunTrust as a 'stay-at-home play'
04/17/20 SunTrust
SciPlay upgraded to Buy from Hold at SunTrust
HTZ Hertz
$3.18 /

-0.07 (-2.15%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
AKBA Akebia
$12.85 /

+0.86 (+7.17%)

05/06/20 RBC Capital
Akebia price target raised to $12 from $8 at RBC Capital
05/05/20 Piper Sandler
Piper Sandler remains a buyer of Akebia following Phase 3 INNO2VATE data
05/05/20 Piper Sandler
Piper says efficacy, safety of FibroGen, Akebia drugs 'quite similar' in DD-CKD
05/05/20 Piper Sandler
Piper sees Akebia shares having 'nice follow through' on pre-market upside
QTWO Q2 Holdings
$81.58 /

-1.04 (-1.26%)

05/08/20 RBC Capital
Q2 Holdings price target raised to $92 from $73 at RBC Capital
04/29/20
Fly Intel: Top five analyst upgrades
04/29/20 Baird
Q2 Holdings upgraded to Outperform at Baird
04/29/20 Baird
Q2 Holdings upgraded to Outperform from Neutral at Baird
  • 13
    May
  • 12
    May
Earnings
iCAD reports Q1 EPS (20c), consensus (13c) » 16:19
05/11/20
05/11
16:19
05/11/20
16:19
ICAD

iCAD

$12.29 /

-0.57 (-4.43%)

Reports Q1 revenue…

Reports Q1 revenue $6.55M, consensus $7.71M.

ShowHide Related Items >><<
ICAD iCAD
$12.29 /

-0.57 (-4.43%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
Over a month ago
On The Fly
Fly Intel: Pre-market Movers » 09:21
04/23/20
04/23
09:21
04/23/20
09:21
IMMU

Immunomedics

$21.98 /

+0.27 (+1.24%)

, LLY

Eli Lilly

$156.64 /

+3.85 (+2.52%)

, BX

Blackstone

$46.36 /

+0.755 (+1.66%)

, SNBR

Sleep Number

$23.00 /

+1.59 (+7.43%)

, LVS

Las Vegas Sands

$41.03 /

+0.345 (+0.85%)

, CTXS

Citrix

$151.55 /

+5.05 (+3.45%)

, IVZ

Invesco

$9.17 /

+0.24 (+2.69%)

, CROX

Crocs

$23.24 /

+0.19 (+0.82%)

, DFS

Discover

$35.04 /

+0.72 (+2.10%)

, TGT

Target

$106.83 /

-0.05 (-0.05%)

, GPS

Gap

$7.12 /

-0.45 (-5.94%)

, ICAD

iCAD

$9.53 /

+0.575 (+6.42%)

, AYX

Alteryx

$116.21 /

+4.99 (+4.49%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
IMMU Immunomedics
$21.98 /

+0.27 (+1.24%)

04/23/20 Wells Fargo
Immunomedics price target raised to $41 from $34 at Wells Fargo
04/23/20 Guggenheim
Immunomedics price target raised to $39 from $35 at Guggenheim
04/23/20 Cowen
Immunomedics price target raised to $45 from $30 at Cowen
04/23/20 H.C. Wainwright
Immunomedics price target raised to $60 from $34 at H.C. Wainwright
LLY Eli Lilly
$156.64 /

+3.85 (+2.52%)

04/21/20
Fly Intel: Top five analyst downgrades
04/21/20 UBS
Eli Lilly downgraded to Neutral from Buy at UBS
04/20/20 UBS
Eli Lilly downgraded to Neutral from Buy at UBS
04/09/20 Morgan Stanley
Morgan Stanley downgrades Eli Lilly to Equal Weight with premium near prior peak
BX Blackstone
$46.36 /

+0.755 (+1.66%)

04/15/20 Wells Fargo
Blackstone price target lowered to $62 from $70 at Wells Fargo
04/14/20 Nomura Instinet
Alnylam risks not absolved with Blackstone deal, says Nomura Instinet
03/19/20 Citi
Blackstone upgraded to Buy from Neutral at Citi
02/10/20 Argus
Blackstone price target raised to $72 from $60 at Argus
SNBR Sleep Number
$23.00 /

+1.59 (+7.43%)

03/25/20 Raymond James
Sleep Number downgraded to Market Perform on weak traffic at Raymond James
03/25/20 Raymond James
Sleep Number downgraded to Market Perform from Outperform at Raymond James
02/20/20 Raymond James
Sleep Number price target raised to $62 from $54 at Raymond James
02/20/20 Wedbush
Sleep Number price target raised to $59 from $45 at Wedbush
LVS Las Vegas Sands
$41.03 /

+0.345 (+0.85%)

04/23/20 JPMorgan
JPMorgan upgrades Las Vegas Sands to Overweight, sees entry point
04/23/20 Deutsche Bank
Las Vegas Sands price target raised to $54 from $50 at Deutsche Bank
04/23/20 Stifel
Las Vegas Sands shares should trade 'sharply higher' after earnings, says Stifel
04/23/20 Nomura Instinet
Las Vegas Sands Q1 not nearly as bad as feared, says Nomura Instinet
CTXS Citrix
$151.55 /

+5.05 (+3.45%)

04/20/20 RBC Capital
Citrix price target raised to $147 from $123 at RBC Capital
04/16/20 Citi
Citrix Q1 should reflect improving secular prospects, says Citi
04/06/20 Deutsche Bank
Citrix price target raised to $175 from $150 at Deutsche Bank
04/03/20 Raymond James
Citrix price target raised to $155 from $124 at Raymond James
IVZ Invesco
$9.17 /

+0.24 (+2.69%)

04/15/20 Citi
Invesco downgraded to Sell from Neutral at Citi
03/16/20 JPMorgan
Invesco price target lowered to $8 from $20 at JPMorgan
02/20/20 Autonomous
Invesco upgraded to Outperform from Neutral at Autonomous
01/03/20 RBC Capital
Invesco downgraded to Sector Perform from Outperform at RBC Capital
CROX Crocs
$23.24 /

+0.19 (+0.82%)

04/15/20 Piper Sandler
Crocs brand momentum remains intact, says Piper Sandler
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
04/06/20 Susquehanna
Crocs price target lowered to $25 remains top pick, says Susquehanna
03/31/20
Fly Intel: Top five analyst initiations
DFS Discover
$35.04 /

+0.72 (+2.10%)

04/13/20 Deutsche Bank
Discover price target lowered to $72 from $95 at Deutsche Bank
04/08/20 Wells Fargo
Discover price target lowered to $53 from $88 at Wells Fargo
03/20/20 Nomura Instinet
Discover upgraded to Buy from Neutral at Nomura Instinet
01/27/20 Stephens
Stephens upgrades 'misunderstood' Synchrony after 10% selloff
TGT Target
$106.83 /

-0.05 (-0.05%)

04/15/20
Fly Intel: Top five analyst upgrades
04/15/20 BMO Capital
Target upgraded to Outperform from Market Perform at BMO Capital
04/08/20 Cowen
Target thesis compelling growth at good price, says Cowen
03/26/20 JPMorgan
Target price target lowered to $113 from $137 at JPMorgan
GPS Gap
$7.12 /

-0.45 (-5.94%)

04/23/20 Morgan Stanley
Morgan Stanley upgrades Gap to Equal Weight following 60% decline
04/23/20 Morgan Stanley
Gap upgraded to Equal Weight from Underweight at Morgan Stanley
03/30/20 Wells Fargo
Gap downgraded to Underweight from Equal Weight at Wells Fargo
03/19/20 Morgan Stanley
Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers
ICAD iCAD
$9.53 /

+0.575 (+6.42%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
AYX Alteryx
$116.21 /

+4.99 (+4.49%)

04/23/20 JPMorgan
Alteryx downgraded to Underweight with $88 price target at JPMorgan
04/23/20 JPMorgan
Alteryx downgraded to Underweight from Neutral at JPMorgan
03/27/20 Citi
Citi opens negative catalyst watch on Alteryx, cuts target to $175
03/24/20 Oppenheimer
Alteryx price target lowered to $135 from $155 at Oppenheimer
Syndicate
iCAD raises $12.5M in a registered direct offering » 07:58
04/23/20
04/23
07:58
04/23/20
07:58
ICAD

iCAD

$9.53 /

+0.575 (+6.42%)

iCAD announced it has…

iCAD announced it has entered into definitive agreements with several institutional investors for the purchase and sale of 1,562,500 shares of the Company's common stock at $8.00 per share, pursuant to a registered direct offering. Craig-Hallum Capital Group is acting as Financial Advisor in connection with the offering.

ShowHide Related Items >><<
ICAD iCAD
$9.53 /

+0.575 (+6.42%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
Hot Stocks
iCAD announces new credit facility with Bridge Bank » 08:34
03/31/20
03/31
08:34
03/31/20
08:34
ICAD

iCAD

$8.32 /

-0.39 (-4.48%)

iCAD announced that it…

iCAD announced that it has entered into a credit facility with Bridge Bank, a division of Western Alliance Bank, effective March 30, 2020. The new credit facility consists of a $7M term loan and a $5M revolving line of credit. The four-year term loan will be interest-only for the first 18 months, which could be extended by an additional six months, if certain conditions are met. The line of credit has a two-year term and may be repaid and reborrowed at any time until its maturity date. "We are pleased to obtain this new financing from Bridge Bank during this period of unprecedented economic impact from the global coronavirus pandemic," said Michael Klein, Chairman and CEO of iCAD. "This new credit facility, and support from Bridge Bank, strengthens our balance sheet and provides us with additional operating flexibility. The novel coronavirus is impacting the healthcare system as a whole. Although we do not provide guidance to investors relating to results of operations, we expect that our results will be impacted as shipping, logistics, installation and training have been delayed and ordering patterns disrupted. We began to see this emerge in March and anticipate that it will continue through Q2."

ShowHide Related Items >><<
ICAD iCAD
$8.32 /

-0.39 (-4.48%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
Conference/Events
iCAD participates in a conference call with JMP Securities » 04:55
03/26/20
03/26
04:55
03/26/20
04:55
ICAD

iCAD

$8.00 /

+0.14 (+1.78%)

Conference call with…

Conference call with management will be held on March 26 hosted by JMP Securities.

ShowHide Related Items >><<
ICAD iCAD
$8.00 /

+0.14 (+1.78%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
Conference/Events
iCAD participates in a conference call with JMP Securities » 10:45
03/24/20
03/24
10:45
03/24/20
10:45
ICAD

iCAD

$7.58 /

+0.45 (+6.31%)

Conference call with…

Conference call with management will be held on March 26 hosted by JMP Securities.

ShowHide Related Items >><<
ICAD iCAD
$7.58 /

+0.45 (+6.31%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
Hot Stocks
iCAD announces launch of new initiatives amid COVID-19 pandemic » 08:37
03/23/20
03/23
08:37
03/23/20
08:37
ICAD

iCAD

$7.45 /

-0.1 (-1.32%)

iCAD announced the launch…

iCAD announced the launch of new initiatives to address emerging challenges hospitals are facing due to the pandemic of the coronavirus disease, or COVID-19. The Company and its portfolio of technologies supporting cancer detection and therapy continue to offer a strong value proposition and multiple benefits to clinicians and patients, which may be particularly relevant in light of the coronavirus outbreak: ProFound AI, the first artificial intelligence software for digital breast tomosynthesis to be FDA-cleared, provides crucial data, such as Case Scores, which can help radiologists prioritize which patients should not delay screening and presents a solution to the growing mammography backlog that will need to be cleared once COVID-19 passes. It is also clinically proven to decrease the rate of false positives and unnecessary recalls,1 which reduces resources needed and minimizes patient risk of COVID-19 exposure. The Xoft Axxent Electronic Brachytherapy System offers a single-fraction therapy option that allows patients who are candidates to replace weeks of daily radiation with one treatment, delivered at the time of surgery. This could also significantly reduce the healthcare system resources needed and reduce patients' risk of COVID-19 exposure. Trained with one of the largest available DBT datasets, ProFound AI rapidly and accurately analyzes each DBT image, or slice, and provides radiologists with key information, such as Certainty of Finding lesion and Case Scores, which assists radiologists in clinical decision-making and improving reading efficiency. Featuring the latest in deep-learning artificial intelligence, the algorithm also allows for continuously improved performance via ongoing updates. The American Society for Radiation Oncology recently recommended shorter courses of radiation therapy, such as intraoperative radiation therapy and hypofractionated radiation therapy, for appropriate patients in its recent recommendations on COVID-19.6 Recognizing the potential for staff reductions, ASTRO advised radiation oncologists to follow evidence-based guidelines while striving for the shortest possible course of radiotherapy, where appropriate. The overall goal is to reduce the risk of transmission of COVID-19 and to allow cancer care to continue for those most likely to benefit. For the treatment of early-stage breast cancer, IORT with the Xoft System offers a single-fraction therapy option that allows patients who are candidates to be treated for breast cancer in just one day. This targeted treatment option enables some women to potentially replace four to six weeks of daily fractions of post-operative external beam radiation therapy with a single-fraction of radiation that can last as little as eight minutes, thereby reducing the amount of time women need to be in the hospital and allowing doctors to treat more women in less time. In addition to early-stage breast cancer, Xoft IORT technology is also being explored in the treatment of other types of tumors. iCAD recently announced the first metastatic brain tumor was treated in the U.S. with IORT using the Xoft System at the James Graham Brown Cancer Center at the University of Louisville. The Xoft System is also currently being studied for the treatment of other types of brain tumors in leading institutions worldwide, including the European Medical Center, one of the largest private medical clinics in Russia and an international leader in comprehensive care and oncology. The Company continues to work with key neurosurgeons to enroll patients in a multi-institutional study on Xoft IORT for the treatment of recurrent glioblastoma.

ShowHide Related Items >><<
ICAD iCAD
$7.45 /

-0.1 (-1.32%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
Hot Stocks
Fly Intel: After Hours Movers » 19:12
02/27/20
02/27
19:12
02/27/20
19:12
SCOR

comScore

$3.00 /

-0.11 (-3.54%)

, FTCH

Farfetch

$9.54 /

-0.33 (-3.35%)

, ZYXI

Zynex

$11.95 /

-0.66 (-5.23%)

, SWN

Southwestern Energy

$1.30 /

-0.11 (-7.83%)

, ICAD

iCAD

$10.86 /

-0.46 (-4.06%)

, NPTN

NeoPhotonics

$6.19 /

-0.125 (-1.98%)

, AMC

AMC Entertainment

$6.08 /

+0.165 (+2.79%)

, TTD

Trade Desk

$250.42 /

-16.58 (-6.21%)

, NKTR

Nektar

$20.59 /

-0.81 (-3.79%)

, FTAI

Fortress Transportation

$18.07 /

-0.8 (-4.24%)

, WDAY

Workday

$171.15 /

-4.19 (-2.39%)

, LYV

Live Nation

$57.73 /

-3.05 (-5.02%)

, OPRX

OptimizeRx

$9.98 /

-1.32 (-11.68%)

, SGMO

Sangamo

$6.67 /

-0.22 (-3.19%)

, FTSV

Forty Seven

$48.78 /

+0.28 (+0.58%)

, BHVN

Biohaven Pharmaceutical

$40.99 /

-3.49 (-7.85%)

, GDI

Gardner Denver

$33.67 /

-2.12 (-5.92%)

, BIG

Big Lots

$22.44 /

-0.36 (-1.58%)

, GPOR

Gulfport Energy

$0.91 /

-0.0949 (-9.44%)

, BYND

Beyond Meat

$106.14 /

-6.31 (-5.61%)

, RUN

Sunrun

$20.32 /

-0.61 (-2.91%)

, CHRS

Coherus Biosciences

$19.18 /

-1.21 (-5.93%)

, GKOS

Glaukos

$61.32 /

-0.03 (-0.05%)

, AAOI

Applied Optoelectronics

$9.56 /

-0.62 (-6.09%)

, VMW

VMware

$135.79 /

-8.51 (-5.90%)

, EB

Eventbrite

$16.98 /

-0.74 (-4.18%)

, AAXN

Axon

$77.16 /

-3.3 (-4.10%)

, MYL

Mylan

$18.62 /

-0.94 (-4.81%)

, IQ

iQIYI

$24.44 /

+0.17 (+0.70%)

, SPPI

Spectrum

$2.41 /

-0.2 (-7.66%)

, DELL

Dell Technologies

$43.63 /

-2.31 (-5.03%)

, CARA

Cara Therapeutics

$15.36 /

-0.55 (-3.46%)

, ADSK

Autodesk

$180.36 /

-10.53 (-5.52%)

, RIGL

Rigel Pharmaceuticals

$2.05 /

-0.13 (-5.96%)

, PSTG

Pure Storage

$15.03 /

-0.835 (-5.26%)

, BBBY

Bed Bath & Beyond

$10.28 /

-0.32 (-3.02%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: comScore (SCOR) up 20.5%... Farfetch (FTCH) up 15.7%... Zynex (ZYXI) up 11.6%... Southwestern Energy (SWN) up 10.0%... iCAD (ICAD) up 10.0%... NeoPhotonics (NPTN) up 10.0%... AMC Entertainment (AMC) up 8.1%... Trade Desk (TTD) up 6.2%... Nektar Therapeutics (NKTR) up 5.9%...Fortress Transportation (FTAI) up 4.0%... Workday (WDAY) up 2.5%... Live Nation (LYV) up 2.2%... OptimizeRX (OPRX) up 2.1%. ALSO HIGHER: Sangamo (SGMO) up 39.5% after entering gene regulation therapy partnership with Biogen... Forty Seven (FTSV) up 29.1% after Bloomberg speculation about approach from Gilead... Biohaven (BHVN) up 6.0% after getting FDA approval for acute treatment of migraine... Garden Denver (GDI) up 2.1% after entering S&P500 index... DOWN AFTER EARNINGS: Big Lots (BIG) down 28.3%... Gulfport Energy (GPOR) down 11.1%... Beyond Meat (BYND) down 10.0%... Sunrun (RUN) down 10.0%... Coherus BioSciences (CHRS) down 8.8%... Glaukos (GKOS) down 7.5%... Applied Optoelectronics (AAOI) down 6.8%... VMWare (VMW) down 6.0%... Eventbrite (EB) down 5.4%... Axon Enterprise (AAXN) down 4.2%... Mylan (MYL) down 3.6%... iQIYI (IQ) down 3.4%... Spectrum Pharma (SPPI) down 3.3%... Dell Technologies (DELL) down 3.3%... Cara Therapeutics (CARA) down 3.2%... Autodesk (ADSK) down 2.6%... Rigel Pharma (RIGL) down 2.5%... Pure Storage (PSTG) down 2.1%. ALSO LOWER: Bed Bath Beyond (BBBY) down 2.0% after announcing strategic restructuring and job cuts. Movers as of 18:30ET.

ShowHide Related Items >><<
SCOR comScore
$3.00 /

-0.11 (-3.54%)

08/07/19 Loop Capital
comScore price target lowered to $5 from $11 at Loop Capital
07/10/19 Needham
comScore price target lowered to $10 from $15 at Needham
06/24/19 Stephens
LiveRamp acquisition of Data Plus Math reasonably priced, says Stephens
05/10/19 Needham
comScore price target lowered to $15 from $28 at Needham
FTCH Farfetch
$9.54 /

-0.33 (-3.35%)

11/15/19 Credit Suisse
Farfetch price target lowered to $17 from $22 at Credit Suisse
11/15/19 KeyBanc
Farfetch price target lowered to $20 from $27 at KeyBanc
11/13/19 Bernstein
Farfetch downgraded to Underperform from Market Perform at Bernstein
11/04/19 Goldman Sachs
Farfetch price target lowered to $21.40 from $37 at Goldman Sachs
ZYXI Zynex
$11.95 /

-0.66 (-5.23%)

09/23/19 H.C. Wainwright
Zynex initiated with a Buy at H.C. Wainwright
06/27/19 B. Riley FBR
Zynex selloff on S-3 filing a buying opportunity, says B. Riley FBR
SWN Southwestern Energy
$1.30 /

-0.11 (-7.83%)

12/18/19 SunTrust
Southwestern Energy initiated with a Hold at SunTrust
12/18/19 SunTrust
Southwestern Energy initiated with a Hold at SunTrust
11/19/19 Johnson Rice
Southwestern Energy downgraded to Hold from Accumulate at Johnson Rice
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
ICAD iCAD
$10.86 /

-0.46 (-4.06%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19 Dougherty
iCAD initiated with a Buy at Dougherty
NPTN NeoPhotonics
$6.19 /

-0.125 (-1.98%)

01/22/20 MKM Partners
NeoPhotonics price target raised to $10.50 from $8.50 at MKM Partners
01/22/20 Needham
NeoPhotonics upgraded to Buy from Hold at Needham
09/23/19 Northland
Inphi drops after Northland sees 'large cut' to Amazon 400G rollout plans
09/18/19 B. Riley FBR
NeoPhotonics downgraded to Neutral from Buy at B. Riley FBR
AMC AMC Entertainment
$6.08 /

+0.165 (+2.79%)

12/18/19
Fly Intel: Top five analyst downgrades
12/18/19 BofA
BofA/Merrill downgrades AMC Entertainment to Underperform with $7 target
12/18/19 BofA
AMC Entertainment downgraded to Underperform from Neutral at BofA/Merrill
11/22/19 B. Riley FBR
B. Riley FBR downgrades Cinemark and Marcus, cuts exhibitor targets
TTD Trade Desk
$250.42 /

-16.58 (-6.21%)

01/22/20 Pivotal Research
Trade Desk price target raised to $320 from $250 at Pivotal Research
01/17/20 Wells Fargo
Trade Desk price target raised to $310 from $240 at Wells Fargo
01/15/20 Stephens
Google cookie announcement widely anticipated, concerns overblown, says Stephens
12/30/19 Rosenblatt
FTC passing on Facebook break-up among Rosenblatt's 2020 Internet predictions
NKTR Nektar
$20.59 /

-0.81 (-3.79%)

02/18/20 Guggenheim
Guggenheim starts Neoleukin Therapeutics at Buy with $20 price target
02/13/20 Cowen
Nektar price target lowered to $30 from $40 at Cowen
02/03/20 Mizuho
Mizuho upgrades Nektar to Buy on 'good risk/reward' into cancer data
02/03/20 Mizuho
Nektar upgraded to Buy from Neutral at Mizuho
FTAI Fortress Transportation
$18.07 /

-0.8 (-4.24%)

12/02/19 BTIG
Fortress Transportation initiated with a Buy at BTIG
12/02/19 BTIG
Fortress Transportation initiated with a Buy at BTIG
11/26/19
Fly Intel: Top five analyst initiations
11/26/19 B. Riley FBR
B. Riley FBR sees 'multiple opportunities' for Fortress Transport shares
WDAY Workday
$171.15 /

-4.19 (-2.39%)

02/21/20 BMO Capital
Workday price target raised to $215 from $200 at BMO Capital
02/20/20 Stifel
Ultimate/Kronos deal highlights demand for modernized HCM solutions, says Stifel
02/20/20
Fly Intel: Top five analyst downgrades
02/20/20 Societe Generale
Workday downgraded to Sell from Hold at Societe Generale
LYV Live Nation
$57.73 /

-3.05 (-5.02%)

01/27/20
Fly Intel: Top five analyst initiations
01/27/20 Cowen
Live Nation initiated with an Outperform at Cowen
01/10/20 Guggenheim
Live Nation consent decree to have muted impact on business, says Guggenheim
12/19/19 Jefferies
Live Nation shares should outperform after DOJ settlement, says Jefferies
OPRX OptimizeRx
$9.98 /

-1.32 (-11.68%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
12/10/19 B. Riley FBR
OptimizeRx named a top idea for 2020 at B. Riley FBR
10/08/19 Lake Street
OptimizeRx deal with NewCrop offers potential sales upside, says Lake Street
SGMO Sangamo
$6.67 /

-0.22 (-3.19%)

02/03/20 Evercore ISI
Evercore ISI downgrades Crispr Therapeutics, questions relative valuation
08/26/19
Fly Intel: Top five analyst initiations
08/26/19 H.C. Wainwright
Sangamo initiated with a Buy at H.C. Wainwright
07/26/19 Canaccord
Homology Medicines selloff yesterday a buying opportunity, says Canaccord
FTSV Forty Seven
$48.78 /

+0.28 (+0.58%)

02/12/20 Mizuho
Forty Seven price target raised to $53 from $37 at Mizuho
01/17/20 Oppenheimer
Forty Seven price target raised to $60 from $35 at Oppenheimer
01/13/20 SunTrust
Forty Seven initiated with a Buy at SunTrust
01/10/20 H.C. Wainwright
H.C. Wainwright impressed by Forty Seven's update, development plan
BHVN Biohaven Pharmaceutical
$40.99 /

-3.49 (-7.85%)

02/14/20 Piper Sandler
Piper says Ubrelvy prescription trajectory bodes well for Biohaven's rimegepant
02/11/20 Mizuho
Biohaven shares have 'significant upside' from here, says Mizuho
02/10/20 Mizuho
Talk with Biohaven CEO gives Mizuho continued confidence in rimegepant
02/10/20 Goldman Sachs
Biohaven Pharmaceutical price target lowered to $76 from $89 at Goldman Sachs
GDI Gardner Denver
$33.67 /

-2.12 (-5.92%)

12/19/19 Vertical Research
Gardner Denver initiated with a Buy at Vertical Research
12/11/19 Morgan Stanley
Morgan Stanley upgrades U.S. Multi-Industry view to Attractive, ups three stock
12/11/19 Morgan Stanley
Fortive upgraded to Overweight, named a top U.S. EE/MI pick at Morgan Stanley
12/09/19 BTIG
Gardner Denver downgraded to Neutral from Buy at BTIG
BIG Big Lots
$22.44 /

-0.36 (-1.58%)

01/21/20 KeyBanc
Big Lots downgraded to Sector Weight from Overweight at KeyBanc
12/09/19 Loop Capital
Big Lots remains a 'show-me story', says Loop Capital
09/03/19 Loop Capital
Big Lots price target raised to $25 from $23 at Loop Capital
08/23/19 Loop Capital
Big Lots price target lowered to $23 from $30 at Loop Capital
GPOR Gulfport Energy
$0.91 /

-0.0949 (-9.44%)

02/11/20 Piper Sandler
Piper downgrades Gulfport, Range Resources on 'deteriorating' outlooks
02/10/20 Piper Sandler
Gulfport Energy downgraded to Neutral from Overweight at Piper Sandler
01/09/20 Wells Fargo
Gulfport Energy downgraded to Underweight at Wells Fargo
01/09/20 Wells Fargo
Gulfport Energy downgraded to Underweight from Equal Weight at Wells Fargo
BYND Beyond Meat
$106.14 /

-6.31 (-5.61%)

02/14/20 Bernstein
Beyond Meat price target raised to $117 from $106 at Bernstein
02/12/20
Fly Intel: Top five analyst initiations
02/12/20 Piper Sandler
Piper starts Beyond Meat at Neutral, says McDonald's deal already priced in
02/11/20 Piper Sandler
Beyond Meat initiated with a Neutral at Piper Sandler
RUN Sunrun
$20.32 /

-0.61 (-2.91%)

02/26/20 Credit Suisse
Sunrun price target raised to $30 from $24 at Credit Suisse
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 KeyBanc
Sunrun downgraded to Sector Weight from Overweight at KeyBanc
01/30/20 Credit Suisse
Tesla signals strong residential solar growth, says Credit Suisse
CHRS Coherus Biosciences
$19.18 /

-1.21 (-5.93%)

02/05/20 Mizuho
Mizuho sees 'immaterial' impact on Coherus shares from BLA withdrawal
11/27/19 Mizuho
Coherus Biosciences said to cancel from conference next week, says Mizuho
11/20/19 Barclays
Symphony data another positive data point for Coherus, says Barclays
09/25/19 Mizuho
Coherus still guiding to 20% exit pegfilgrastim volume market share, says Mizuho
GKOS Glaukos
$61.32 /

-0.03 (-0.05%)

01/06/20 Berenberg
Glaukos upgraded to Buy from Hold at Berenberg
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
12/12/19 Wells Fargo
Glaukos downgraded to Underweight from Overweight at Wells Fargo
10/24/19 Stephens
Glaukos could benefit from Allergan's 'unfortunate' XEN hold, says Stephens
AAOI Applied Optoelectronics
$9.56 /

-0.62 (-6.09%)

11/05/19 Rosenblatt
Applied Optoelectronics upgraded to Buy ahead of guidance at Rosenblatt
11/05/19 Rosenblatt
Applied Optoelectronics upgraded to Buy from Neutral at Rosenblatt
10/22/19 JPMorgan
Applied Optoelectronics downgraded to Underweight on valuation at JPMorgan
10/22/19 JPMorgan
Applied Optoelectronics downgraded to Underweight from Neutral at JPMorgan
VMW VMware
$135.79 /

-8.51 (-5.90%)

02/11/20
Crowdstrike upgraded to Buy at DA Davidson on ARR growth potential
02/06/20
Fly Intel: Top five analyst upgrades
02/06/20 Bernstein
VMware upgraded to Outperform from Market Perform at Bernstein
01/23/20 Jefferies
Citrix price target raised to $115 from $105 at Jefferies
EB Eventbrite
$16.98 /

-0.74 (-4.18%)

01/24/20 William Blair
Data shows Eventbrite fan engagement is growing, says William Blair
11/08/19 BMO Capital
Square price target lowered to $78 from $92 at BMO Capital
07/08/19 JPMorgan
Eventbrite refund program for Roxodus a near-term risk, says JPMorgan
06/17/19
Fly Intel: Top five analyst initiations
AAXN Axon
$77.16 /

-3.3 (-4.10%)

02/24/20 JPMorgan
Axon price target raised to $92 from $78 at JPMorgan
02/24/20 JPMorgan
Axon price target raised to $92 from $78 at JPMorgan
02/20/20 Morgan Stanley
Axon downgraded to Equal Weight on valuation at Morgan Stanley
02/20/20 Morgan Stanley
Axon downgraded to Equal Weight from Overweight at Morgan Stanley
MYL Mylan
$18.62 /

-0.94 (-4.81%)

02/06/20 BMO Capital
Biogen price target raised to $317 from $297 at BMO Capital
02/05/20 Baird
Biogen price target raised to $290 from $250 at Baird
02/05/20 Mizuho
Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
02/05/20 Wedbush
Wedbush remains Neutral on Biogen shares despite US PTAB decision
IQ iQIYI
$24.44 /

+0.17 (+0.70%)

02/27/20 JPMorgan
iQIYI upgraded to Neutral with $22 price target at JPMorgan
02/26/20 JPMorgan
iQIYI upgraded to Neutral from Underweight at JPMorgan
01/30/20 CLSA
iQIYI price target raised to $23.50 from $19 at CLSA
01/21/20 HSBC
iQIYI upgraded to Buy from Hold at HSBC
SPPI Spectrum
$2.41 /

-0.2 (-7.66%)

12/27/19 B. Riley FBR
Spectrum price target lowered to $11 from $18 at B. Riley FBR
12/26/19 Guggenheim
Spectrum downgraded to Neutral from Buy at Guggenheim
12/26/19
Spectrum price target lowered to $11 from $41 at H.C. Wainwright
12/26/19 Cantor Fitzgerald
Spectrum downgraded to Neutral from Overweight at Cantor Fitzgerald
DELL Dell Technologies
$43.63 /

-2.31 (-5.03%)

02/06/20
Fly Intel: Top five analyst initiations
02/06/20 RBC Capital
Dell Technologies initiated with a Sector Perform at RBC Capital
12/23/19 Citi
Citi names Amphenol top pick, cuts Celestica to Sell into 'Year of Connectivity'
11/27/19 Credit Suisse
Dell Technologies price target lowered to $55 from $61 at Credit Suisse
CARA Cara Therapeutics
$15.36 /

-0.55 (-3.46%)

01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
12/19/19 Piper Sandler
Cara Therapeutics risk/reward 'compelling' at these levels, says Piper Jaffray
12/04/19 Cantor Fitzgerald
Cara Therapeutics price target raised to $33 from $29 at Cantor Fitzgerald
12/03/19 Stifel
Stock pressure on Cara dismisses achievement of dose finding goal, says Stifel
ADSK Autodesk
$180.36 /

-10.53 (-5.52%)

02/21/20 Citi
Autodesk price target raised to $250 from $210 at Citi
02/19/20 Baird
Autodesk assumed with an Outperform at Baird
02/18/20 RBC Capital
Autodesk price target raised to $220 from $205 at RBC Capital
01/21/20 Deutsche Bank
Autodesk upgraded to Buy from Hold at Deutsche Bank
RIGL Rigel Pharmaceuticals
$2.05 /

-0.13 (-5.96%)

01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
01/13/20 Piper Sandler
Rigel still one of the most under-appreciated stories in sector, says Piper
11/15/19
Fly Intel: Top five analyst initiations
11/15/19 Cantor Fitzgerald
Rigel Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
PSTG Pure Storage
$15.03 /

-0.835 (-5.26%)

01/17/20 Morgan Stanley
Morgan Stanley downgrades IBM to Equal Weight as IT hardware budgets pressured
11/22/19 Cowen
Pure Storage price target lowered to $19 from $23 at Cowen
11/22/19 Barclays
Pure Storage Q3 results 'clearly a disappointment,' says Barclays
11/12/19 JPMorgan
Pure Storage risk/reward profile 'very attractive,' says JPMorgan
BBBY Bed Bath & Beyond
$10.28 /

-0.32 (-3.02%)

02/24/20 Morgan Stanley
Bed Bath & Beyond results may get worse before better, says Morgan Stanley
02/13/20 JPMorgan
Bed Bath & Beyond price target lowered to $10 from $13 at JPMorgan
02/12/20 Raymond James
Bed Bath & Beyond price target lowered to $14 from $17 at Raymond James
02/12/20 Loop Capital
Bed Bath & Beyond price target lowered to $12 from $15 at Loop Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.